Skip to main content

Advertisement

ADVERTISEMENT

Volume 19 - Issue 5 - May, 2007

Feature

Case Report
08/01/2008
Islam Bolad, MD and Lawrence O'Meallie, MD
Islam Bolad, MD and Lawrence O'Mealli...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Sigrid Nikol, MD, William W. O’Neill, MD, Joseph Babb, MD, Jorge Belardi, MD, Timothy Henry, MD, Robert Simari, MD
Sigrid Nikol, MD, William W. O’Neil...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Robert Simari, MD
Robert Simari, MD
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Ravi K. Ramana, DO, David J. Wilber, MD, Ferdinand Leya, MD
Ravi K. Ramana, DO, David J. Wilber, ...
Case Study. A 56-year-old male with severe nonischemic cardiomyopathy and recurrent ventricular tachycardia (VT) presented to our cardiology clinic with complaints of intermittent palpitations and several implantable cardioverter...
Case Study. A 56-year-old male with severe nonischemic cardiomyopathy and recurrent ventricular tachycardia (VT) presented to our cardiology clinic with complaints of intermittent palpitations and several implantable cardioverter...
Case Study. A 56-year-old male...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Kevin P. Theleman, MD, Charles M. Gottlich, MD, Jeffrey M. Schussler, MD
Kevin P. Theleman, MD, Charles M. Got...
Case Report. A 65-year-old male with no known history of coronary disease presented with dyspnea on exertion and electrocardiographic (ECG) changes suggesting an old inferior infarct. Stress testing suggested ischemia based on ECG criteria....
Case Report. A 65-year-old male with no known history of coronary disease presented with dyspnea on exertion and electrocardiographic (ECG) changes suggesting an old inferior infarct. Stress testing suggested ischemia based on ECG criteria....
Case Report. A 65-year-old male...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Fernando Alfonso, MD, PhD, Diego Martín, MD, *Felipe Fernández-Vázquez, MD
Fernando Alfonso, MD, PhD, Diego Mart...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
*Brian C. Downey, MD,**Kenneth G. Warner, MD, *Carey Kimmelstiel, MD
*Brian C. Downey, MD,**Kenneth G. War...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
a,b,dRobert D. Ecker, MD, a,b,c,dElad I. Levy, MD, a,b,c,dL. Nelson Hopkins, MD
a,b,dRobert D. Ecker, MD, a,b,c,dEla...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Rami Kharouf, MD, Qi-Ling Cao, MD, Ziyad M. Hijazi, MD, MPH
Rami Kharouf, MD, Qi-Ling Cao, MD, Zi...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC, FACA Editor-in-Chief
Richard E. Shaw, PhD, FACC, FACA Edit...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement